# How does Liraglutide promote osteogenic differentiation in dental pulp stem cells?

Canonical source: https://retacompare.com/research/how-does-liraglutide-promote-osteogenic-differentiation-in-dental-pulp-stem-cells

Peptide Longevity Q&A · 2026-03-18


    Liraglutide significantly enhances the proliferation and osteogenic differentiation of dental pulp stem cells (DPSCs) by promoting histone lactylation and activating the dentin sialophosphoprotein (DSPP) gene, which is crucial for bone regeneration.

 What the research shows

This study investigated the effects of Liraglutide (LIRA), a glucagon-like peptide-1 receptor agonist, on dental pulp stem cells (DPSCs), which are vital for periodontal tissue regeneration. The research aimed to assess LIRA's impact on DPSC proliferation and osteogenic differentiation. Various assays, including Cell Counting Kit-8, 5-Ethynyl-2'-deoxyuridine staining, alkaline phosphatase (ALP), and alizarin red S (ARS) assays, were employed to measure these effects. The study also quantified histone lactylation levels and evaluated the enrichment of H3K18 lactylation at the DSPP promoter using chromatin immunoprecipitation (ChIP) and dual-luciferase assays. The results indicated that LIRA significantly enhanced DPSC proliferation and osteogenic differentiation, as evidenced by increased ALP activity, mineralization nodules, and upregulation of osteogenic markers such as DMP1, DSPP, RUNX2, OCN, and OPN.

 Why it matters for longevity

The findings of this research are significant within the context of longevity and regenerative medicine. Osteogenic differentiation is crucial for maintaining bone health and integrity, particularly as individuals age. By promoting the proliferation and differentiation of DPSCs, Liraglutide may contribute to improved periodontal health and bone regeneration, potentially mitigating age-related bone density loss and enhancing overall healthspan. The study also highlights the role of metabolic-epigenetic pathways, specifically the H3K18 lactylation-DSPP axis, in regulating osteogenic processes, which could have broader implications for understanding how metabolic factors influence aging and tissue regeneration.

 Key findings at a glance

Liraglutide enhances DPSC proliferation and osteogenic differentiation.

Increased alkaline phosphatase activity and mineralization nodules were observed.

Osteogenic markers DMP1, DSPP, RUNX2, OCN, and OPN were upregulated.

Liraglutide elevated global lactylation and H3K18 lactylation levels.

ChIP assays showed H3K18 lactylation enrichment at the DSPP promoter.

Oxamate reversed Liraglutide's effects, while Nala amplified them.

 How Liraglutide works (background)

Liraglutide functions as a glucagon-like peptide-1 receptor agonist, which means it mimics the action of incretin hormones that promote insulin secretion and inhibit glucagon release. Beyond its metabolic effects, Liraglutide has been shown to possess anti-inflammatory and bone-protective properties. In the context of this research, Liraglutide's ability to enhance osteogenic differentiation in DPSCs is linked to its promotion of histone lactylation, a process that modifies chromatin structure and influences gene expression. The activation of the DSPP gene, essential for dentin and bone formation, is a key outcome of this histone modification, indicating that Liraglutide may help regulate important pathways involved in bone regeneration.

 Safety, caveats, and what we don't yet know

While the study demonstrates promising results regarding Liraglutide's effects on DPSCs, it is important to note that this research is preclinical and conducted in vitro. The findings may not directly translate to in vivo systems or human populations without further investigation. Additionally, the safety profile of Liraglutide in the context of long-term use for bone regeneration remains to be fully established. Future studies should explore the effects of Liraglutide in diverse populations and its potential interactions with other therapeutic agents.

 Bottom line

The research indicates that Liraglutide promotes osteogenic differentiation in dental pulp stem cells through histone lactylation-mediated activation of the DSPP gene, suggesting its potential role in enhancing periodontal regeneration.

 Related questions

 Can Liraglutide enhance muscle regeneration in aging individuals?

Research suggests that Liraglutide's effects on cellular proliferation and differentiation may extend beyond dental pulp stem cells, potentially influencing muscle regeneration, although specific studies are needed to confirm this.

 Does Liraglutide have effects on age-related bone density loss?

Given Liraglutide's role in promoting osteogenic differentiation, it may help mitigate age-related bone density loss, but further research is necessary to establish its efficacy in clinical settings.

 What is the role of histone lactylation in aging?

Histone lactylation is an emerging area of research that suggests metabolic changes can influence gene expression related to aging and tissue regeneration, warranting further exploration in the context of longevity.

 Source: PubMed · Tissue Eng Regen Med · published 2026-03-18.

## Sources

- PubMed · Tissue Eng Regen Med: https://pubmed.ncbi.nlm.nih.gov/41849034/